Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
FREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq:CTKB), a leading cell analysis solutions company, has signed an agreement with the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) to drive technological innovation and accelerate discoveries for the scientific community.
Related news for (CTKB)
- Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/04/25 05:00 PM
- MoBot’s Stock Market Highlights – 06/04/25 04:00 PM
- MoBot alert highlights: NASDAQ: CTKB, NASDAQ: LYEL, NYSE: NCL, NYSE: BURU, NASDAQ: MFI (06/04/25 03:00 PM)
- Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference